This conference is accredited by the European Board for Accreditation in Hematology (EBAH) CME system. Participants will be eligible to claim CME credit points.
The meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior scientists and clinicians (MD, PhD)
• PhD candidates and clinical residents still in-training
Learning Objectives:
Update on the pathophysiology of MGUS, SMM and myeloma.
Update on the diagnostic criteria and the use of new assessments
Treatment of fit myeloma patients
Treatment of frail myeloma patients
Optimal sequencing at early and late relapse
The role of new immunotherapy approaches
Role of novel drugs
Latest updates in other plasma cell disorders beyond myeloma
Scientific Topics:
– MGUS
– Smouldering myeloma
– Characterising multiple myeloma
– Newly-diagnosed fit multiple myeloma patients
– Role of frailty for treatment decisions
– Personalising treatment in multiple myeloma
– Relapsed multiple myeloma
– Novel technologies for tailored treatment
– Amyloidosis and Waldenstrom’s Disease
The programme will include:
– Plenary Sessions
– Panel Discussions
– Debates
– Poster Walks
– Simultaneous Meet the Expert Sessions
– Ample time for in-depth discussion
Register here
Direct email queries to: [email protected]
